Clinical Research Directory
Browse clinical research sites, groups, and studies.
Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis
Sponsor: Indonesia University
Summary
The goal of this clinical trial is to compare drug vonoprazan vs esomeprazole effectiveness to relieve early symptoms in Erosive Esophagitis Patients. It will also learn about the safety of both modalities. The main questions it aims to answer are: How does the effectiveness of Vonoprazan compare with Esomeprazole in improving early symptoms of erosive esophagitis patients in the Indonesian population? Researchers will compare drug vonoprazan to a esomeprazole with a look-alike packaging to see their effect to reduce early symptoms of erosive esophagitis. Participants will: * Take drug vonoprazan 20mg or esomeprazole 40mg one time every day for 2 weeks * Visit the clinic once every weeks for followup (Gastro Esophageal Reflux Disease-Quetionnaire measurement) * Keep a diary of their adverse effect occurence and every variable data based on Gastro Esophageal Reflux Disease-Questionnaire.
Official title: Comparison of the Effectiveness of Vonoprazan and Esomeprazole in Improving Initial Symptoms in Patients with Erosive Esophagitis: a Double-Blind Randomized Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
216
Start Date
2024-12-09
Completion Date
2025-06-27
Last Updated
2024-12-17
Healthy Volunteers
No
Conditions
Interventions
Vonoprazan 20 mg
Vonoprazan PO, 20mg, once a day, 14 days.
Esomeprazole
Esomeprazole PO, 40mg, once a day, 14 days
Locations (5)
Hermina Jatinegara Hospital
East Jakarta, DKI Jakarta, Indonesia
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia
Hermina Kemayoran Hospital
Jakarta Pusat, DKI Jakarta, Indonesia
Hermina Bekasi Hospital
Bekasi, West Java, Indonesia
Hermina Depok Hospital
Depok, West Java, Indonesia